Source: Pain Medicine. Conference titles: Annual Meeting of The American Academy of Pain Medicine (AAPM). Unidade: FMRP
Subjects: DOR, PELVE, MULHERES, ENDOMETRIOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLI NETTO, Omero Benedicto et al. Plasma levels of metalloproteinases 2 (MMP-2) and 9 (MMp-9) from women with chronic pelvic pain (CPP) secondary to endometriosis or myofascial syndrome are not elevated when compared to healthy subjects. Pain Medicine. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 17 out. 2024. , 2011APA
Poli Netto, O. B., Rocha, M., Gomes, V., Rosa e Silva, J. C., Tanus-Santos, J. E., Reis, F. J. C. dos, & Nogueira, A. A. (2011). Plasma levels of metalloproteinases 2 (MMP-2) and 9 (MMp-9) from women with chronic pelvic pain (CPP) secondary to endometriosis or myofascial syndrome are not elevated when compared to healthy subjects. Pain Medicine. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Poli Netto OB, Rocha M, Gomes V, Rosa e Silva JC, Tanus-Santos JE, Reis FJC dos, Nogueira AA. Plasma levels of metalloproteinases 2 (MMP-2) and 9 (MMp-9) from women with chronic pelvic pain (CPP) secondary to endometriosis or myofascial syndrome are not elevated when compared to healthy subjects. Pain Medicine. 2011 ; 12( 3): 520.[citado 2024 out. 17 ]Vancouver
Poli Netto OB, Rocha M, Gomes V, Rosa e Silva JC, Tanus-Santos JE, Reis FJC dos, Nogueira AA. Plasma levels of metalloproteinases 2 (MMP-2) and 9 (MMp-9) from women with chronic pelvic pain (CPP) secondary to endometriosis or myofascial syndrome are not elevated when compared to healthy subjects. Pain Medicine. 2011 ; 12( 3): 520.[citado 2024 out. 17 ]